Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab.
Hosseini
Hamid
H
Razeghinejad
Mohammad Reza
MR
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005128:Eye Diseases / Q000188:drug therapy; D005260:Female; D005451:Fluorescein Angiography / Q000379:methods; D006801:Humans; D007276:Injections, Intraventricular / Q000009:adverse effects*; D018917:Optic Neuropathy, Ischemic / Q000139:chemically induced*; D012307:Risk Factors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab